| Invasive fungal infections in the intensive care unit L Ostrosky-Zeichner, M Al-Obaidi Infectious Disease Clinics 31 (3), 475-487, 2017 | 70 | 2017 |
| Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial GR Thompson, A Soriano, OA Cornely, BJ Kullberg, M Kollef, J Vazquez, ... The Lancet 401 (10370), 49-59, 2023 | 67 | 2023 |
| Evolution of Cefiderocol Non-Susceptibility in Pseudomonas aeruginosa in a Patient Without Previous Exposure to the Antibiotic AP Streling, MM Al Obaidi, WD Lainhart, T Zangeneh, A Khan, AQ Dinh, ... Clinical Infectious Diseases 73 (11), e4472-e4474, 2021 | 48 | 2021 |
| The prevention of COVID-19 in high-risk patients using tixagevimab–cilgavimab (Evusheld): Real-world experience at a large academic center MM Al-Obaidi, AB Gungor, SE Kurtin, AE Mathias, B Tanriover, ... The American journal of medicine 136 (1), 96-99, 2023 | 34 | 2023 |
| Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action M Hoenigl, R Sprute, A Arastehfar, JR Perfect, C Lass-Flörl, R Bellmann, ... Expert opinion on investigational drugs 31 (8), 795-812, 2022 | 25 | 2022 |
| Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston … M Al-Obaidi, R Hasbun, KJ Vigil, AR Edwards, V Chavez, DR Hall, ... Open Forum Infectious Diseases 6 (7), ofz172, 2019 | 23 | 2019 |
| Race and ethnicity: Risk factors for fungal infections? JD Jenks, CI Aneke, MM Al-Obaidi, M Egger, L Garcia, T Gaines, ... PLoS pathogens 19 (1), e1011025, 2023 | 18 | 2023 |
| Effectiveness of casirivimab-imdevimab monoclonal antibody treatment among high-risk patients with severe acute respiratory syndrome coronavirus 2 B. 1.617. 2 (Delta variant … MM Al-Obaidi, AB Gungor, S Nematollahi, TT Zangeneh, EJ Bedrick, ... Open forum infectious diseases 9 (7), ofac186, 2022 | 12 | 2022 |
| Perinephric abscess in a renal transplant recipient due to Mycoplasma hominis: Case report and review of the literature M Adams, R Bouzigard, M Al‐Obaidi, TT Zangeneh Transplant Infectious Disease 22 (5), e13308, 2020 | 11 | 2020 |
| Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA. 2, BA. 2.12. 1 and BA. 5 subvariants dominated era S Sridhara, AB Gungor, HK Erol, M Al-Obaidi, TT Zangeneh, EJ Bedrick, ... Plos one 18 (4), e0279326, 2023 | 9 | 2023 |
| The utility of (1→ 3)-β-d-glucan testing in the diagnosis of coccidioidomycosis in hospitalized immunocompromised patients MM Al-Obaidi, P Ayazi, A Shi, M Campanella, E Connick, TT Zangeneh Journal of Fungi 8 (8), 768, 2022 | 6 | 2022 |
| A comparative analysis of mucormycosis in immunosuppressed hosts including patients with uncontrolled diabetes in the Southwest United States M Al-Obaidi, B Youssefi, J Bardwell, R Bouzigard, CH Le, TT Zangeneh The American Journal of Medicine 134 (9), 1155-1159, 2021 | 5 | 2021 |
| Pulmonary mucormycosis in a heart transplant patient J Bardwell, B Youseffi, J Marquez, TT Zangeneh, M Al-Obaidi The American journal of medicine 133 (9), e524-e525, 2020 | 5 | 2020 |
| Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis MM Al-Obaidi, L Ostrosky-Zeichner, DE Nix Open Forum Infectious Diseases 10 (8), ofad345, 2023 | 4 | 2023 |
| The impact of nirmatrelvir-ritonavir in reducing hospitalizations among high-risk patients with SARS-CoV-2 during the omicron predominant era MM Al-Obaidi, AB Gungor, S Murugapandian, B Thajudeen, I Mansour, ... The American journal of medicine 136 (6), 577-584, 2023 | 4 | 2023 |
| Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature M Al‐Obaidi, H Badali, C Cañete‐Gibas, HP Patterson, NP Wiederhold Mycoses 64 (6), 616-623, 2021 | 4 | 2021 |
| Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus M Al-Obaidi, P Younes, L Ostrosky-Zeichner Oxford Medical Case Reports 2018 (10), omy062, 2018 | 4 | 2018 |
| New onset seizures and CNS tuberculoma FA Khasawneh, MM Al-Obaidi QJM: An International Journal of Medicine 108 (3), 261-262, 2015 | 4 | 2015 |
| Remarks on the universal lifelong coccidioidomycosis prophylaxis in lung transplant recipients MM Al-Obaidi, S Nematollahi, DE Nix, TT Zangeneh Clinical Infectious Diseases 74 (10), 1885-1886, 2022 | 3 | 2022 |
| Fixed dosing of amphotericin B in morbidly obese individuals DE Nix, JF Hayes, M Al Obaidi, T Zangeneh Clinical Infectious Diseases 72 (9), e431-e431, 2021 | 2 | 2021 |
